Dobromir D.
- Country
- Bulgaria
- Department
- BG10003: Department of Internal Medicine
Research Overview
- Efficacy and Safety of Linaprazan Glurate versus Lansoprazole for Maintenance of Healing in Patients with Healed Erosive Esophagitis Due to Gastroesophageal Reflux Disease
- Evaluation of Guselkumab and Golimumab Combination Therapy Efficacy and Safety in Moderate to Severe Ulcerative Colitis: A Phase 2b Randomized Controlled Trial
- Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 99 of 276 partner sites.
Specializations
Inflammatory Bowel Disease Specialty
This investigator specializes in treating patients with ulcerative colitis, with particular emphasis on moderate to severe cases. Their research focuses on innovative therapeutic approaches for managing inflammatory bowel conditions.
- Moderate to Severe Ulcerative Colitis Management
- Biologic Therapy Assessment
- Combination Treatment Strategies
Their expertise extends to evaluating novel biological treatments and comparative therapeutic approaches in gastroenterology.
Therapeutic Innovation
The investigator's work encompasses the evaluation of biosimilar medications and their therapeutic equivalence to established treatments. They focus on advancing treatment options for inflammatory bowel conditions.
- Biosimilar Development
- Comparative Efficacy Studies
- Treatment Response Assessment
Their research contributes to expanding the therapeutic arsenal available for treating inflammatory bowel diseases.
Advanced Treatment Protocols
The investigator studies combination therapy approaches in gastroenterology, particularly focusing on the synergistic effects of multiple biological agents. Their work includes evaluation of treatment outcomes in refractory cases.
- Multi-drug Treatment Strategies
- Long-term Efficacy Assessment
- Treatment Response Monitoring
Their research explores innovative therapeutic combinations to enhance treatment outcomes in inflammatory bowel disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.